• Return to Headlines

After Yesterday's Decline of 1.67%, Myriad Genetics Offers Investors Better Value

By Amy Schwartz

Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $25.96 to a high of $26.92. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $26.20 on volume of 238,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend is monitoring the recent change of momentum in Myriad Genetics. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Myriad Genetics in search of a potential trend change.

Over the past year, Myriad Geneticshas traded in a range of $25.96 to $50.01 and are now at $25.96. Over the last five market days, the 200-day moving average (MA) has gone down 0.9% while the 50-day MA has declined 0.8%.

Keywords: rebounders myriad genetics

Ticker(s): MYGN